Honkanen V E
Fourth Department of Medicine, Helsinki University Central Hospital, Finland.
Scand J Rheumatol. 1991;20(6):385-91. doi: 10.3109/03009749109096816.
The reactive oxygen radicals are trapped by anti-oxidants, such as selenium containing glutathione peroxidase (GSHpx), which also can inhibit the oxygenation of arachidonic acid to pro-inflammatory prostaglandins and leukotrienes. We studied the levels of anti-oxidant glutathione peroxidase and selenium (in plasma) in 48 patients with rheumatoid arthritis (RA). In the multiple regression model, joint score had the highest explanatory value for serum selenium, and sulphasalazine treatment was the most significant variable contributing to GSHpx activity. The plasma GSHpx activity was not increased in RA patients in general, but was high in those taking sulphasalazine as compared with those not doing so (342.4 +/- 48.2 vs. 298.9 +/- 34.7 U/l, 95% confidence interval of difference from 17.9 to 69.1, p less than 0.002). The serum selenium levels correlated with clinical activity of the joint, disease measuring joint score.
活性氧自由基被抗氧化剂捕获,如含硒的谷胱甘肽过氧化物酶(GSHpx),其还可抑制花生四烯酸氧化为促炎前列腺素和白三烯。我们研究了48例类风湿性关节炎(RA)患者抗氧化剂谷胱甘肽过氧化物酶和(血浆中)硒的水平。在多元回归模型中,关节评分对血清硒的解释价值最高,而柳氮磺胺吡啶治疗是对GSHpx活性影响最显著的变量。一般而言,RA患者血浆GSHpx活性并未升高,但与未服用柳氮磺胺吡啶的患者相比,服用该药物的患者其活性较高(342.4±48.2 vs. 298.9±34.7 U/l,差异的95%置信区间为17.9至69.1,p<0.002)。血清硒水平与关节的临床活动度、疾病测量关节评分相关。